Open Tender for Bisacodyl Tablets (V2) in NORTH DELHI, DELHI

The eligibility requirements for this tender include being a registered entity with the appropriate licenses to manufacture and supply pharmaceutical products. Suppliers must demonstrate prior experience in delivering similar products, compliance with health regulations, and adherence to quality standards in production. Documentation for verification of eligibility must be provided during the submission process.

To participate in this tender, suppliers must present several documents, including but not limited to, a valid manufacturing license, quality compliance certificates, and proof of registration with relevant health authorities. All required certificates should be up-to-date and must comply with the local pharmaceutical regulations, ensuring they meet the necessary technical specifications outlined by the issuing authority.

Document submission should be conducted electronically via the designated procurement platform. Acceptable formats include PDF for official documents, as they provide a secure presentation of data. Ensure that all submitted documents are clear, legible, and comply with the site’s requirements to avoid any potential issues during evaluation.

The payment terms for this tender will be specified within the contract upon bid acceptance, typically including provisions for an Earnest Money Deposit (EMD). Additionally, suppliers may be required to furnish a performance security to guarantee the contract's execution, which is often calculated as a percentage of the total bid. Final terms regarding these aspects will be detailed in the contractual agreement after selection.

MSEs participating in this tender may benefit from a special provision that encourages their involvement in government procurement. By supporting Micro, Small, and Medium Enterprises (MSEs), the tender process helps enhance local production, aligns with the Make in India initiative, and promotes inclusive economic growth. This can include concessions in evaluation criteria and enhanced opportunity for bid acceptance compared to larger entities.